Quetiapine
Quetiapine is the comparator because it has a robust evidence base in bipolar depression. If quetiapine remains superior, ASCEnD findings would reinforce caution about antidepressant use in bipolar depression. Quetiapine monotherapy has be…
1 sources - 5 claims
Quetiapine is the comparator because it has a robust evidence base in bipolar depression. If quetiapine remains superior, ASCEnD findings would reinforce caution about antidepressant use in bipolar depression. Quetiapine monotherapy has been described as more cost-effective than other bipolar depression treatments. The ASCEnD medication guide suggests a quetiapine maximum dose of 300 mg/day. Quetiapine is one of the few NICE-recommended treatments and is widely prescribed in primary care.